Please use this identifier to cite or link to this item:
Title: Acupuncture for comorbid depression and insomnia in perimenopause: A feasibility patient-assessor-blinded, randomized, and sham-controlled clinical trial.
Austin Authors: Zhao, Fei-Yi;Zheng, Zhen;Fu, Qiang-Qiang;Conduit, Russell;Xu, Hong;Wang, Hui-Ru;Huang, Yu-Ling;Jiang, Ting;Zhang, Wen-Jing;Kennedy, Gerard A 
Affiliation: School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.
Yangpu Hospital, School of Medicine, Tongji University, Shanghai, China.
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.
Institute for Breathing and Sleep
Issue Date: 2023 2023
Publication information: Frontiers in public health 2023; 11:1120567
Abstract: Whilst acupuncture is widely used for treating psychosomatic diseases, there is little high-quality evidence supporting its application in comorbid perimenopausal depression (PMD) and insomnia (PMI) which are common complaints during climacteric. This feasibility, patient-assessor-blinded, randomized, sham-controlled clinical trial addresses this gap by investigating the efficacy and safety of acupuncture on depressed mood and poor sleep in women with comorbid PMD and PMI.
DOI: 10.3389/fpubh.2023.1120567
Journal: Frontiers in public health
Start page: 1120567
PubMed URL: 36815166
ISSN: 2296-2565
Type: Journal Article
Subjects: acupuncture
clinical trial
comorbid depression and insomnia
hormone levels
non-pharmacologic intervention
Acupuncture Therapy/methods
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Mar 30, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.